Learn More
Selleck Chemical LLC Rezivertinib E4675-1G

Supplier: Selleck Chemical LLC E46751G
Rezivertinib(BPI-7711) is a potent third-generation inhibitor of EGFR tyrosine kinase targeting both EGFR-sensitizing mutations and the EGFR T790M mutation Additionally it has excellent CNS penetration and has antitumor activity
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.